The FDA approval is based on the OASIS 4 Phase 3 clinical trial a 64-week study of 307 adults with obesity or overweight and at least one weight-related health condition (such as high blood pressure, high cholesterol, or prediabetes), but without type 2 diabetes
May Reduce Risk of Kidney Disease Lower the risk of worsening kidney disease, kidney failure (end-stage kidney disease), and death due to cardiovascular disease in adults who also have chronic kidney disease
Frontiers in Endocrinology (2023) This comprehensive review looked at 39 different studies to understand how GLP-1 medications and another type of diabetes medication, SGLT2 inhibitors, affect pregnancy and breastfeeding
If your regimen is mainly tablet-based, Oral Diabetes Medication can help you understand the terms screeners may use
It works by mimicking the action of a naturally occurring hormone in the body called glucagon-like peptide-1 (GLP-1)